Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Clinical trial NCT05985681 · RECRUITING

Trial details

NCT number: NCT05985681
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus-Related Carcinoma

Start date: 2026-01-27
Primary completion: 2028-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.